  <div class="data-description" style="background-color: #f2f2f2; padding: 10px;">
     <h4>The above data are published on GEO as GSE243665 series</h4>
    <h4>Data Descriptions:</h4>
    <p>
    The Shiny App allows the creation of virtual organoids (VO) incorporating user-defined genetic heterogeneity. VO offer a valuable platform for validating computational methods dedicated to characterizing tumor heterogeneity through single-cell analysis.
    </p>
        <br>

    <p>PC9, 4492 sequenced cells
      <a href="https://pubmed.ncbi.nlm.nih.gov/21167064/" target="_blank">(EGFR Del19, activating mutation)</a>
    </p>
    <br>
    <p>A549, 6898 sequenced cells
      <a href="https://pubmed.ncbi.nlm.nih.gov/20358631/" target="_blank">(KRAS p.G12S, growth and proliferation)</a>
    </p>
    <br>
    <p>NCI-H596 (HTB178), 2965 sequenced cells
      <a href="https://pubmed.ncbi.nlm.nih.gov/35636967/" target="_blank">(MET Del14 , enhanced protection from apoptosis and cellular migration)</a>
    </p>
    <br>
    <p>NCI-H1395 (CRL5868), 2673 sequenced cells
      <a href="https://pubmed.ncbi.nlm.nih.gov/32540409/" target="_blank">(BRAF p.G469A, gain of function, resistant to all tested MEK +/âˆ’ BRAF inhibitors)</a>
    </p>
    <br>
    <p>DV90, 2998 sequenced cells
      <a href="https://pubmed.ncbi.nlm.nih.gov/23220880/" target="_blank">(ERBB2 p.V842I, increases kinase activity)</a>
    </p>
    <br>
    <p>HCC78, 2748 sequenced cells
      <a href="https://pubmed.ncbi.nlm.nih.gov/22919003/" target="_blank">(SLC34A2-ROS1 Fusion, ROS1 inhibitors have antiproliferative effect)</a>
    </p>
    <br>
    <p>CCL.185.IG, 6354 sequenced cells
      <a href="https://www.atcc.org/products/ccl-185ig" target="_blank">(EML4-ALK Fusion-A549 Isogenic Cell)</a>
    </p>
  </div>

